Crescent Capital BDC Inc (CCAP) Stock Forecast & Price Target
Crescent Capital BDC Inc · NASDAQ
$10.94+0.10 (+0.92%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Crescent Capital BDC Inc, 3 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $12.00 to $16.50, so the covering firms are broadly aligned. The average target of $14.33 sits 31% above the current $10.94. The rating mix has stayed broadly stable, with Buy-side ratings easing from 4 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.38 next quarter toward $1.50 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy350%
Hold350%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Crescent Capital BDC Inc.
As of Jul, 3 of 6 firms rate CCAP a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CCAP EPS & revenue forecast
EPS · NEXT QUARTER
$0.38
Range $0.36 – $0.39 · 6 analysts · -18% YoY
Next period, 6 analysts expect Crescent Capital BDC Inc to earn $0.38 a share (range $0.36 – $0.39), versus $0.46 a year earlier. Full-year consensus is $1.55, growing to $1.50 the year after.
REVENUE · NEXT QUARTER
$37.2M
Range $35.8M – $38.8M · 6 analysts · -10% YoY
Revenue is expected to reach $37.2M (range $35.8M – $38.8M), -10.0% year-over-year. Full-year consensus is $149.7M, rising to $147.6M next year.
Top analysts covering Crescent Capital BDC Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CCAP.
#1
Robert Dodd
Raymond James · Rank #57
Buy
$17.00+55.4% to target
Overall win rate
44%
+ Follow
#2
Finian O'Shea
Wells Fargo · Rank #82
Hold
$12.00+9.7% to target
Overall win rate
48%
+ Follow
#3
PJ
Paul Johnson
Keefe, Bruyette & Woods
Buy
$13.00+18.8% to target
Coverage
—
+ Follow
#4
Mitchel Penn
Oppenheimer
Hold
$16.00+46.3% to target
Coverage
—
+ Follow
#5
DH
Derek Hewett
B of A Securities
Buy
$17.00+55.4% to target
Coverage
—
+ Follow
CCAP stock forecast FAQ
What is CCAP's average 12-month price target?+
The 6 analysts with a live target average $14.33 for Crescent Capital BDC Inc over the next 12 months, ranging from a $16.50 high to a $12.00 low.
Is CCAP stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 3 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CCAP?+
The Street-high target is $16.50 (Clear Street), and the Street-low is $12.00 (Wells Fargo). The average of all 6 active targets is $14.33.
How many Wall Street analysts cover CCAP?+
6 analysts have an active rating on Crescent Capital BDC Inc, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering CCAP?+
Among analysts who currently cover CCAP, Robert Dodd of Raymond James has the strongest overall Quantellect track record (Rank #57). Their current call is Buy with a $17.00 target.
What is Crescent Capital BDC Inc's projected EPS for next quarter?+
The consensus estimate is $0.38 per share (range $0.36 – $0.39) across 6 analysts. Full-year EPS is projected at $1.55, rising to $1.50 the following year.
How much revenue is Crescent Capital BDC Inc expected to report next quarter?+
Consensus revenue is $37.2M (range $35.8M – $38.8M). Full-year revenue is projected at $149.7M, growing to $147.6M next year.
Have analysts been upgrading or downgrading CCAP lately?+
As of Jul, 3 of 6 firms rate CCAP a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CCAP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
